Silperisone Hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSilperisone Hydrochloride
Drug Alias Namesilperisona西哌立松silperisonum西哌立松盐酸盐SILA-336 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type II alpha subunit blockersSodium channel protein type V alpha subunit blockers
TargetsSodium channel protein type II alpha subunitSodium channel protein type V alpha subunit
Therapy Area/IndicationsMuscle Spasticity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGedeon Richter Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGedeon Richter Plc
Active IndicationsN/A
Inactive IndicationsMuscle Spasticity

Other Information

ATC CodeN/A
Related LinksWikipedia